Reducing Gadolinium Contrast With Artificial Intelligence

Area of Science:

• Radiology and Medical Imaging
• Artificial Intelligence in Medicine
• Neuroimaging

Background:

• Gadolinium contrast agents are crucial for MRI, especially in neuroimaging, aiding diagnosis of inflammatory, infectious, and neoplastic conditions by detecting blood-brain barrier breakdown.
• However, gadolinium contrast use is associated with significant risks, including nephrogenic systemic fibrosis, gadolinium deposition in brain and bone tissues, and allergic-like reactions.
• The evolution of computer hardware and AI presents opportunities to mitigate these risks.

Purpose of the Study:

• To review the clinical applications of gadolinium contrast agents in MRI, with a focus on neuroimaging.
• To summarize the known risks and adverse effects associated with gadolinium contrast administration.
• To explore the current state-of-the-art machine learning (ML) methods for reducing or eliminating gadolinium contrast doses in neuroimaging and discuss their limitations.

Main Methods:

• Literature review of clinical uses, risks, and ML applications related to gadolinium contrast in MRI.
• Focus on studies applying ML techniques to neuroimaging to reduce contrast agent administration.
• Analysis of current ML methods, their efficacy, and limitations in the context of gadolinium reduction.

Main Results:

• Gadolinium contrast agents are vital for diagnosing various neurological conditions via MRI.
• Identified risks include NSF, gadolinium deposition, and allergic reactions.
• Emerging ML techniques show promise in reducing or eliminating gadolinium contrast while maintaining diagnostic quality.

Conclusions:

• Machine learning offers a potential solution to minimize gadolinium contrast-related risks in MRI.
• Further research and validation of ML algorithms are needed for widespread clinical adoption in neuroimaging.
• AI-driven approaches could enhance MRI safety and accessibility by reducing reliance on gadolinium contrast agents.